Muscle Disuse Atrophy
9
1
2
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
22.2%
2 terminated out of 9 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Muscle Response to Different Amounts of Dietary Protein During Leg Immobilization
Examining Sex-based Differences in Metabolic and Mechanistic Responses to Disuse Induced Muscle Atrophy
n3 PUFA and Muscle-disuse Atrophy in Older Women
The Effects of Protein Supplementation With or Without Urolithin A During Single-leg Immobilization
Effect of a Natural Source Supplementation on Muscle Mass
Strength Training Augmenting Rehabilitation
Muscle Damage and Disuse Atrophy
Can Supplemental Leucine Offset Disuse-induced Muscle Atrophy?
Neuromuscular Electrical Stimulation During Immobilization Due to Ankle Fractures